ProShares Ultra Nasdaq Biotechnology · $102M$13,367
BIBBIB vsSSOSSOProShares - Ultra S&P500 · $8.4B$20,633
$10,000 five years ago, dividends reinvested · they hold 16.7% in common
BIBMeasureSSO
Returns · dividends reinvested
+49.0%Year to dateJan 1 → Nov 3+17.1%
+66.5%1 yearTotal return+16.4%
+44.6%3 years · per year$10,000 became $30,262 · $28,308+41.5%
+6.0%5 years · per year$10,000 became $13,367 · $20,633+15.6%
Cost and income
1.17%Expense ratio$117 · $88 a year on $10k · lower is better0.88%
0.19%Trailing 12-mo yield$19 · $71 a year on $10k0.71%
Risk · past year
−17.9%Worst dropSmaller is better−18.2%
44.7%VolatilityLower is calmer25.4%
BIBSSO Winner of the row, in its colourEach row: the bigger of the two fills its side
4–4Level
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns